Short-term Effects of Pure Anti-oestrogen ICI 182780 Treatment on Oestrogen Receptor, Epidermal Growth Factor Receptor and Transforming Growth Factor-alpha Protein Expression in Human Breast Cancer

By McClelland R.A.   Gee J.M.W.   Francis A.B.   Robertson J.F.R.   Blamey R.W.   Wakeling A.E.   Nicholson R.I.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 413-416

Elsevier

Access to resources Recommend Favorite

Characterization of a human breast cancer cell line, MCF-7/RU58^R-1, resistant to the pure antiestrogen RU 58,668

By Fog C.   Christensen I.   Lykkesfeldt A.  

Breast Cancer Research and Treatment, Vol. 91, Iss. 2, 2005-05 ,pp. : 133-144

Springer Publishing Company

Access to resources Recommend Favorite

Tumor Necrosis Factor-α Induces Interleukin-6 Production via Extracellular-Regulated Kinase 1 Activation in Breast Cancer Cells

By Suarez-Cuervo C.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 1, 2003-07 ,pp. : 71-78

Springer Publishing Company

Access to resources Recommend Favorite

TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression

By Bjerre Christina   Vinther Lena   Belling Kirstine   Würtz Sidse   Yadav Rachita   Lademann Ulrik   Rigina Olga   Do Khoa   Ditzel Henrik   Lykkesfeldt Anne   Wang Jun   Nielsen Henrik   Brünner Nils   Gupta Ramneek   Schrohl Anne-Sofie   Stenvang Jan  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3839-3851

Springer Publishing Company

Access to resources Recommend Favorite

Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine

By Sui Meihua  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite